Introduction
Oct-4 is a POU transcription factor that is highly expressed in embryonic stem cells (ESCs), embryonic epiblasts and primordial germline cells (PGCs) [1] [2] [3] . The precise level of Oct-4 tightly regulates the differentiation capacity of ESCs. Loss of Oct-4 expression in ESCs results in a loss of pluripotency and the induction of trophectoderm differentiation 4, 5 . In contrast, doubling Oct-4 levels in ESCs induces differentiation toward the mesodermal and endodermal embryonic lineages 4 . Oct-4 is normally expressed in early tissues including oocyte, blastocysts and embryonic ectoderm before gastrulation 1, 2 . Oct-4 is absent in HSCs and is only detected at high levels in germ tissue of adults 2, 6 . Maintaining expression of Oct-4 during ESC differentiation has been shown to have effects on neurogenesis and hematopoiesis 7, 8 .
In this study, we have utilized an ESC line (ZHBTc4) in which both endogenous Oct-4
alleles have been deleted and a tetracycline-repressible Oct-4 transgene has been introduced 4 .
When Oct-4 expression was repressed at the beginning of differentiation (day 0), formation of EBs was severely hindered and there was a decrease in the expression of hematopoietically associated genes. Similar results were observed when we stably transfected the cells with the basic helix-loop-helix transcription factor SCL 9, 10 . However, if Oct-4 was allowed to express for 48 hours after induction for differentiation, the expression of SCL was able to rescue the ESCs to form functional hematopoietic EBs. Our study demonstrates that Oct-4 is essential for at least two different roles in hematopoiesis. It must first specify brachyury-positive mesoderm and then facilitate the proper hematopoietic development of uncommitted mesoderm.
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Methods

Embryonic stem cells
ZHBTc4 ESCs were generated and cultured as previously described 4 . Full-length SCL cDNA was subcloned into the pCAPP chicken -actin promoter-containing vector. ZHBTc4 cells were electroporated with pCAPP parental or SCL/pCAPP vector using the BioRad Gene Pulser (240 V, 500 μFD). Puromycin (2.5μg/ml) (Sigma) was added to culture medium 48 hours after electroporation for clonal selection. All ZHBTc4 and ZHBTc4-derived ESCs (pCAPP control and SCL clones) are Oct-4 knockout cells with tet-regulated Oct-4 transgene.
RT-PCR analysis
Total RNA was extracted from multiple clones of pCAPP control or SCL ZHBTc4 clones using RNeasy (Qiagen). First strand cDNA was synthesized using the Invitrogen cDNA synthesis kit according to the manufacturer's instructions. Primers used for PCR reactions are shown in Table   S1 11 .
Immunoblots
Total protein was extracted from undifferentiated ESCs or differentiating EBs using 1X lysis 
Differentiation of ESCs into Embryoid Bodies
Embryoid bodies were generated from ESCs either in liquid culture or in semi-solid media. For liquid culture, ESCs were cultured in primary differentiation medium according to an established protocol 15 . For differentiation in semi-solid media, pCAPP control or SCL clones were cultured in conditions as previously described 12 .
Microscopy
Photomicrographs of EBs formed after 12-14 days cultured in methylcellulose medium were taken by Axioskop Fluorescence microscopy (Carl Zeiss, Thornwood, NY) via a 10X objective.
Images taken via AxioCam camera (Carl Zeiss) were analyzed with Slidebook software (Olympus, Center Valley, PA).
Flow Cytometry
Day 14 EBs were collected and disaggregated in 0.25% collagenase at 37 o C for one hour. Singlecell suspensions were collected, washed and incubated with 100 μl of antibody cocktail (CD45-PE and CD11b-APC) (1:100) (BD Biosciences) at ambient temperature for 30 minutes. Cells were washed once and resuspended in PBS for FACS analysis (FACSCalibur) (Becton Dickinson). Data collected were analyzed by FlowJo software (Tree Star Inc.)
CD11b staining of Macrophages from Embryoid Bodies
Immunocytochemistry was performed as previously described 13 .
Results and discussion
Lack of Oct-4 in ESCs hinders embryoid body formation and inhibits hematopoiesis. In pluripotent ESCs, any disruption of Oct-4 natural expression pattern results in an increase or decrease of their mesodermal commitment 4, 7 . To investigate whether there is a possible role for Oct-4 during hematopoietic differentiation, we systematically switched off Oct-4 at different time points using a tet-regulated, Oct-4 knock-in ESC line (ZHBTc4) and examined EB generation. Both EB formation and hematopoietic development were hampered when Oct-4 was turned off at day 0 ( Figure S1A ). RT-PCR analyses showed both mesodermal and hematopoietic markers (SCL, BMP4, Brachyury (bry), flk1, PU.1, EKLF, embryonic globin and EpoR) were repressed ( Figure S1B ).
Since SCL is an early-acting factor required for hematopoietic stem cell development from mesoderm, we generated SCL-expressing ZHBTc4 ESCs (SCL clones) to determine if SCL clones could bypass the requirement for Oct-4 in hematopoiesis ( Figure S2 ) 10 . SCL failed to rescue hematopoiesis when Oct-4 was silenced at day 0 of differentiation ( Figure 1A ). Major mesodermal and hematopietic markers (bry, PU.1 and EKLF) were downregulated in both tettreated control and SCL clones ( Figure S3 ). However, an increase expression in various globin genes (α-, ζ-and βmaj-) was noted from the tet-treated SCL ESCs but not the tet-treated control ( Figure S3 ). In conclusion, we have revealed a novel role for Oct-4 in embryonic development beyond the initial specification of early bry+ mesoderm. By shutting off Oct-4 expression immediately after the formation of early mesoderm we have shown that Oct-4 is necessary for hematopoietic development. However, this requirement can be bypassed by the expression of SCL in mesoderm.
SCL rescues hematopoietic differentiation when
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